Skip to main content

Biotech Funding Trends: Insights from Entrepreneurs and Investors

Biotech Funding Trends: Insights from Entrepreneurs and Investors

Alexandra Carina Gruber

ISBN: 978-3-527-32435-4

Feb 2009

210 pages

In Stock

$154.95

Description

Based on interviews with successful biotech entrepreneurs and high-level investors as well as case studies, this title provides a comprehensive overview of current trends in biotech funding. In particular, it illustrates the tensions between both sides based on their different backgrounds and expectations. The book outlines the various funding opportunities for the biotech industry and identifies ways for both sides to overcome their existing prejudices in order to successfully thrive in a competitive environment.
A must-have for biotech entrepreneurs and investors, as well as invaluable supplementary reading for students aspiring to a career in the industry.
INTRODUCTION
Development of the Private Equity and Venture Capital Market
Development of the Biotech Industry
METHODOLOGY
Formulating the Research Goal
Conducting the Study
Evaluating the Results
DATA ANALYSIS AND INTERPRETATION OF RESULTS
Description of Interview Partners
Major Characteristics of an Entrepreneur
Major Characteristics of a Venture Capitalist
The Most Important Partnering Criteria
Financing Models
Biotech Research Areas
Alliances and Funding in the Early Stage
Alliances and Funding in the Late Stage
Exit Routes
Primary Causes of Failure
Best-practice Countries for Funding Biotech Start-ups
Striking Differences between the US and European Venture Capital Markets
BIOTECH CASE STUDIES
AUSTRIANOVA Biomanufacturing AG
AVIR Green Hills Biotechnology AG
EUCODIS GmbH
Intercell AG
onepharm Research & Development GmbH
SUMMARY AND CONCLUSIONS
The Challenge: When Science Meets Business
Checklists
Final Observations
OUTLOOK AND RECOMMENDATIONS
EPILOGUE
REFERENCES
APPENDICES
""Gruber has become a veteran of marketing and business development in the pharmaceutical industry around the world, specializing in marketing and licensing biotechnological and generic products. She conducted qualitative interviews with entrepreneurs, venture capitalists, and other investors about the interpersonal and financial aspects of starting a biotech company, and presents the results here. By describing the characteristics beliefs, and expectations of each of the groups, she hopes to help investors and entrepreneurs build relationships based on mutual understanding that will lead to greater success in the biotech business, and most especially European companies in competition with American ones."" (SciTech Book News, December 2010)

  • Provides a comprehensive overview of current trends in biotech funding

  • Based on interviews with dedicated biotech entrepreneurs and high-level investors as well as case studies

  • Illustrates the tensions between both sides based on their different backgrounds and expectations

  • Identifies ways for both sides to overcome their existing prejudices in order to successfully thrive in a competitive environment

  • Outlines the various funding opportunities for the biotech industry in Europe